Biologics

• Published in: Techniques in vascular and interventional radiology Vol. 23; no. 4; p. 100704
• Main Authors: Bowers, Robert L., Troyer, Wesley D., Mason, Rudolph A., Mautner, Kenneth R.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2020
• Subjects: Animals; Evidence-Based Medicine; Humans; Mesenchymal Stem Cell Transplantation - adverse effects; mesenchymal stromal cell; Musculoskeletal Diseases - diagnosis; Musculoskeletal Diseases - physiopathology; Musculoskeletal Diseases - therapy; orthobiologics; osteoarthritis; Platelet-Rich Plasma; tendinopathy; Treatment Outcome; orthobiologics; mesenchymal stromal cell; platelet-rich plasma; osteoarthritis; tendinopathy
• ISSN: 1089-2516; 1557-9808
• DOI: 10.1016/j.tvir.2020.100704

Biologics are a growing field that has shown immense promise for the treatment of musculoskeletal conditions both in orthopedic sports medicine and interventional pain management. These procedures utilize injection of supraphysiologic levels of platelets and growth factors to invoke the body's own inflammatory cascade to augment the healing of many bony and soft tissue conditions. While many patients improve with conservative care, there is a need to address the gap between those that improve with rehabilitation alone and those who ultimately require operative management. Orthobiologic procedures have the potential to fill this void. The purpose of this review is to summarize the basic science, evidence for use, and post-injection rehabilitation concepts of platelet-rich plasma (PRP) and mesenchymal stromal cells (MSCs) as they pertain to joints, tendons, ligaments, and the spine.